4th Annual Peptides Congress
April 24-25, 2017
April 24, 2017 - 17:20-17:50
Steffen Weinbrenner, Ph.D., Head of Drug Discovery at Polyphor, will be a speaker at the 4th Annual Peptides Congress – April 24-25, 2017 in London, England.
Dr. Weinbrenner’s presentation entitled:
" Peptidic and Non-peptidic Macrocycles for Challenging Targets in Drug Discovery"
• Peptidic Macrocycles – from Discovery to clinics
• Design of Non-peptidic Macrocycles for oral applications
• Chemical Optimization of Macrocycles – a case study”.
Steffen Weinbrenner Biography
Steffen Weinbrenner, Ph.D. is Head Drug Discovery at Polyphor. He has over 20 years experience in drug discovery and early development with multiple chemical modalities. He started his career in 1996 with Byk Gulden GmbH as a research scientist working in the field of Combinatorial and Medicinal Chemistry on drug discovery projects in various indication areas such as respiratory, oncology and gastroenterology. In 2003 he was appointed Head of Department Lead Finding Chemistry at Altana Pharma AG, responsible for Lead generation. In 2007 he was promoted to Director of Global Medicinal Chemistry at Nycomed overseeing synthetic chemistry, chemical outsourcing, molecular modeling and drug design with sites in Konstanz (Germany) and Mumbai (India). In 2009 he became Director Discovery Technologies responsible for HTS, discovery outsourcing, molecular modeling and drug design, discovery data management, compound management and ADMET. In 2011 he joined Polyphor leading discovery and early development of macrocycle drugs. Steffen received his Ph.D. on the total synthesis of cyclopeptidic natural products in 1995 under supervision of Prof. Dr. U. Schmidt at the University of Stuttgart.